Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adults.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melox is a selective COX‑2 inhibitor used to manage inflammatory joint diseases and short‑term pain.

Osteoarthritis: reduces joint pain and improves mobility. Rheumatoid arthritis: decreases inflammation and slows disease progression. Ankylosing spondylitis: alleviates spinal stiffness and pain. Acute pain: provides rapid relief of moderate to severe pain.

Melox may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset (nausea, dyspepsia) - Headache - Dizziness - Elevated blood pressure - Peripheral edema - Mild skin rash

Serious or Rare Side Effects: - Gastrointestinal ulcer or bleeding - Cardiovascular events (myocardial infarction, stroke) - Hepatic enzyme elevation - Severe skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Acute renal impairment - Anaphylactic reactions

Before prescribing Melox, clinicians should evaluate patient‑specific risk factors and monitor therapy.

Assess renal function: adjust use in patients with impaired kidney function. Monitor hepatic enzymes: discontinue if significant liver injury occurs. Evaluate cardiovascular risk: avoid in patients with recent myocardial infarction or uncontrolled hypertension. Avoid concurrent use with other NSAIDs or anticoagulants unless medically necessary. Store at ambient temperature below 25°C: keep in the original container, protect from moisture.

Melox can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Methotrexate: possible increased toxicity. - ACE inhibitors or diuretics: potential reduction in renal function. - SSRIs or SNRIs: additive risk of bleeding.